glp 1 triple agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. Retatrutide is a agonist. It targets GLP-1, GIP, and glucagon receptors. Ozempic targets one. Mounjaro Novo Nordisk said on Tuesday

Gerson believed that cancer and other chronic diseases resulted from toxin accumulation and nutritional deficiencies that could be reversed through intensive dietary intervention

An animal model of glutathione depletion demonstrated a significant increase in oxidative stress during exercise

Medicine (Baltimore) 99(45):e22976 Cao W et al (2022) Clostridium butyricum potentially improves inflammation and immunity through alteration of the microbiota and metabolism of gastric cancer patients after gastrectomy

Before taking any supplements, it is always advisable to speak to a doctor.

Portion control is key

A safety update on sodium glucose co-transporter 2 inhibitors